October 26, 2021 -- PerkinElmer has introduced Signals Research Suite, a cloud-based informatics platform geared toward pharmaceutical and industrial customers.
Signals Research Suite offers integrated scientific data and workflow management aimed at streamlining workflows and helping clients make decisions on drug, compound, and formulation candidates, according to the vendor. It is available as a software as a service solution deployed on Amazon Web Services.
The new suite blends PerkinElmer Informatics' Signals Notebook electronic lab notebook; Signals VitroVivo 3.0 (formerly Signals Screening) data processing platform; and Signals Inventa 3.0 (formerly Signals Lead Discovery) data management, integration, and analytics platform. This combination enables data capture, search, publishing, and sharing; raw data conversion from other systems and sources; and visual analytics and predictive modeling, according to PerkinElmer.